Research Interest

a.TGF beta signaling pathway in glioblasoma b.Cancer stem cell c.Radiation biology

Education

Doctor--Oncology--Tongji Medical College,HUST,Wuhan, Hubei, P.R. China--2005

Master--Oncology--Tongji Medical College,HUST,Wuhan, Hubei, P.R. China--2001

Bachelor--Public Health--Tongji Medical College,Wuhan, Hubei, P.R. China--1997

Oversea Study and Visit

Post Doctoral,German Cancer Research Center (DKFZ) /Heiderg University,Germany,2009-12-07-2011-10-21

Academic Memberships

Honours and Awards

Honours and Awards

[1] Zhang M, Kleber S, Röhrich M, Timke C, Han N, Tuettenberg J, Martin-Villalba A, Debus J, Peschke P, Wirkner U, Lahn M, Huber PE.,Blockade of TGF-β signaling by the TGFβR-I kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma,Cancer Res.,2011,

[2] Zhang M, Herion TW, Timke C, Han N, Hauser K, Weber KJ, Peschke P, Wirkner U, Lahn M, Huber PE,Trimodal glioblastoma treatment consisting of concurrent radiotherapy, temozolomide, and the novel TGF-β receptor I kinase inhibitor LY2109761,Neoplasia,2011,

[3] Zhang M, Lahn M, Huber PE,Translating the combination of TGFβ blockade and radiotherapy into clinical development in glioblastoma,Oncoimmunology,2012,

[4] Han N, Li W, Zhang M,The function of the RNA-binding protein hnRNP in cancer metastasis,J Cancer Res Ther.,2013,

[5] Yongsheng Li, Na Han, Tiejun Yin, LuluHuang, Shunfang Liu, Dongbo Liu, Cuihong Xie, Mengxian Zhang,Lentivirus mediated Nox4 shRNA inhibits invasion, angiogenesis and enhances radiosensitivity in human glioblastoma,Oxidative medicine and cellular longevity,2014,